N
MNTA

Nuveen’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Nuveen’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-787,080
Closed -$41.3M – 3415
2020
Q3 		$41.3M Sell
787,080
-82,216
-9% -$3.4M 0.02% 661
2020
Q2 		$28.9M Sell
869,296
-59,973
-6% -$1.91M 0.01% 817
2020
Q1 		$25.3M Buy
929,269
+376,796
+68% +$10.5M 0.01% 778
2019
Q4 		$10.9M Buy
552,473
+173,598
+46% +$2.78M ﹤0.01% 1546
2019
Q3 		$4.91M Sell
378,875
-2,749
-0.7% -$33.2K ﹤0.01% 1963
2019
Q2 		$4.75M Buy
+381,624
New +$5.07M ﹤0.01% 2023

Nuveen's MNTA Position: Q4 2020 in Review

Nuveen sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 787,080 shares — an estimated $41.3M sold.

Nuveen first reported a position in MNTA in Q2 2019 and held it in 6 quarters. The position peaked at $41.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Nuveen reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Nuveen sold 787,080 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $41.3M.
  • Nuveen first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2019 and held it in 6 quarters.
  • Nuveen's Momenta Pharmaceuticals, Inc. position peaked at $41.3M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.